Breast Imaging Market, by Technology (Ionizing Breast Imaging {Mammography, Positron Emission Tomography-Computed Tomography (PET-CT), Molecular Breast Imaging (MBI)}, Non-ionizing Breast Imaging {Ultrasound, MRI, Image-guided breast biopsy}, and others);

Breast Imaging Market, by Technology (Ionizing Breast Imaging {Mammography, Positron Emission Tomography-Computed Tomography (PET-CT), Molecular Breast Imaging (MBI)}, Non-ionizing Breast Imaging {Ultrasound, MRI, Image-guided breast biopsy}, and others); by end user (hospitals, diagnostic centres and others (specialty clinics, ambulatory surgical centres, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Breast cancer is leading cause of death among women. Wide variety of tools and technologies are used to screen, detect and diagnose breast cancer. Mammography, ultrasound, MRI, Image-guided breast biopsy, positron emission tomography, computed tomography (PET-CT) among others are the technologies which are used to diagnose breast cancer. Current breast imaging modalities play a vital role in assisting clinicians in the primary screening of cancer, treatment selection, and treatment progress monitoring.

Market Dynamics

Surge in prevalence of breast cancer is likely to drive demand for imaging modalities and thereby drive growth of market. For instance, according to World Health Organization, there were estimated 2.3 million women diagnosed with breast cancer globally in 2020. Moreover, breast imaging integrated with artificial intelligence has brought advancement in breast imaging. This is expected to drive growth of market. Furthermore, growing awareness regarding breast cancer is leads to increase number of cancer diagnoisis screening and thereby drive the growth of market. For instance, National Breast Cancer Foundation, Inc, a non-profit organization is engaged in raising awareness regarding breast cancer screening. Mammograghy is a technique for early detection of breast cancer and is widely used in developed countries. Additionally, newer types of mammogram such as 3D mammography have become more popular. Thus, increase in popularity and usage of innovative imaging technologies for breast cancer is likely to create a potential opportunity for market growth

Key features of the study:

• This report provides an in-depth analysis of the global breast imaging market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global breast imaging market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc, Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global breast imaging market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global breast imaging market

Detailed Segmentation:

• Global Breast Imaging Market, By Technology:
• Ionizing Breast Imaging
• Mammography
• Positron Emission Tomography-Computed Tomography (PET-CT)
• Molecular Breast Imaging (MBI)
• Non-ionizing Breast Imaging
• Ultrasound
• MRI
• Image-guided breast biopsy
• Others - Automated Whole-breast Ultrasound (AWBU), Thermography, etc.
• Global Breast Imaging Market, By End User:
• Hospitals
• Diagnostic Centers
• Others (Specialty Clinics, Ambulatory Surgical Centers, etc.)
• Global Breast Imaging Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• GE Healthcare*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Siemens Healthcare GmbH
• Seno Medical
• Koninklijke Philips N.V.
• Fujifilm Holdings Corporation
• Hologic, Inc.
• Aurora Imaging Technologies, Inc.
• Canon Inc
• Dilon Technologies, Inc.
• Leica Biosystems Nussloch GmbH (Danaher)
• Carestream Health
• Avante Health Solutions
• Hitachi, Ltd
• PLANMED OY
• Barco

“*” marked represents similar segmentation in other categories in the respective section.